KYMR Crosses Above Average Analyst Target

In recent trading, shares of Kymera Therapeutics Inc (Symbol: KYMR) have crossed above the average analyst 12-month target price of $69.20, changing hands for $70.15/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgradeIn recent trading, shares of Kymera Therapeutics Inc (Symbol: KYMR) have crossed above the average analyst 12-month target price of $69.20, changing hands for $70.15/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgradeRead MoreMarkets,Stocks,ETFsStocks Feed